A Feasibility Study to Assess the Use of Gadolinium in Computed Tomography

NCT02163005 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped No patients enrolled as study did not move to enrollment stage

Conditions

Contrast Media Allergy

Interventions

DRUG: Gadolinium

Sponsor

Massachusetts General Hospital